Owner Odyssey Pharmaceuticals, Inc.

Inventors Galarneau, Andre; Michnick, Stephen W.

Agent Mallesons

Pub. Number AU-B-2008201746

Parent 2002213587

Filing date 21 April 2008

Wipo publication date 8 May 2008

Acceptance publication date 8 March 2012

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/78 (2006.01) Enzymes, e.g. ligases (6.) - acting on carbon to nitrogen bonds other than peptide bonds (3.5)

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/34 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

G01N 21/78 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/531 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Production of immunochemical test materials

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent